Advice
Following a full submission
ulipristal acetate (EllaOne®) is accepted for use within NHS Scotland for emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure. When administered within the licensed time frame for ulipristal or an active comparator for emergency hormonal contraception, contraceptive efficacy with ulipristal was non-inferior to that with the comparator in individual studies and statistically superior in a meta-analysis of two studies.
Other treatments are available at lower drug acquisition cost.
Download detailed advice87KB (PDF)
Medicine details
- Medicine name:
- ulipristal (EllaOne)
- SMC ID:
- 599/10
- Indication:
- Emergency contraception
- Pharmaceutical company
- HRA Pharma UK Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 08 February 2010